Novo Nordisk Reports 19% Sales Growth to DKK 78.1 Billion in Q1 2025
Novo Nordisk Reports Strong Operating Profit and Sales Growth, Updates 2025 Outlook Novo Nordisk announced a 22% increase in operating profit in Danish kroner, or 20% growth at constant exchange…
Roche Launches Elecsys PRO-C3 Test to Enhance Accuracy in Liver Fibrosis Assessment
Roche (SIX: RO, ROG; OTCQX: RHHBY) has announced the launch of its Elecsys® PRO-C3 test, a new diagnostic tool developed in collaboration with Nordic Bioscience, to assess the severity of…
Health Inequities Are Cutting Lives Short by Decades
Global Health Inequities Slashing Lifespans by Decades, WHO Warns A new report by the World Health Organization (WHO) reveals that the root causes of poor health often lie outside the…
Teva and Alvotech Receive FDA Approval for SELARSDI™ as an Interchangeable Biosimilar to Stelara
Teva and Alvotech Expand U.S. Biosimilar Portfolio with Approval for SELARSDI™ Teva Pharmaceuticals, the U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Alvotech (NASDAQ: ALVO) have…
WHO Reminds Us: Gloves Are No Replace for Hand Hygiene
WHO Highlights the Importance of Hand Hygiene Over Gloves on World Hand Hygiene Day Hand hygiene remains one of the most effective, affordable, and universal tools in preventing the spread…
Johnson & Johnson Unveils Oncology Care Index, Exposing Gaps Between Cancer Innovation and Real-World Practice
73% of healthcare professionals (HCPs) report a disconnect between the availability of cutting-edge treatments and their effective implementation in clinical practice, while 3 in 4 oncologists say the rapid pace…
TREMFYA® Sustains Remission in Ulcerative Colitis Through Two Years
TREMFYA® Shows Sustained Long-Term Remission in Ulcerative Colitis Patients, According to Phase 3 QUASAR LTE Study More than 70% of patients in clinical remission and over 40% in endoscopic remission…
GSK advances the future of respiratory medicine and patient care with new data presented at ATS
GSK to Present 43 Abstracts Across Respiratory Portfolio at ATS 2025, Including New Data on Mepolizumab and Depemokimab GSK plc (LSE/NYSE: GSK) today announced that 43 abstracts, including four late-breaking…
Sanofi Highlights Scientific Leadership and Innovation in Chronic Inflammatory Respiratory Diseases at ATS
Sanofi Showcases Expansive Respiratory Innovation and Scientific Leadership at ATS 2025 with Robust Clinical Data from Dupixent and Immunology Pipeline Sanofi is poised to make a major impact at the…
Amgen Announces First Quarter 2025 Financial Performance
Amgen Posts Strong First Quarter 2025 Financial Results, Driven by Robust Product Demand and Strategic Launches Amgen Inc. (NASDAQ: AMGN) reported its financial results for the first quarter of 2025,…
Breztri Achieves Primary Endpoints in Pivotal Phase III KALOS and LOGOS Trials for Asthma
AstraZeneca’s Breztri Achieves Primary Endpoints in KALOS and LOGOS Phase III Trials, Marking a Significant Advance in the Treatment of Uncontrolled Asthma AstraZeneca announced encouraging high-level results from its pivotal…
BOTOX® Cosmetic Advances Its Commitment to Entrepreneurial Empowerment with “The Confidence Project”
BOTOX® Cosmetic Expands Commitment to Female Empowerment with The Confidence Project for Women Entrepreneurs In a bold move to champion female entrepreneurship and narrow the persistent confidence gap between men…